CJ

Cedergren Jan

Director Director DIN 02662832
DIN 02662832 First appointment Apr 2008 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Apr 2008
Shareholding value Locked Premium profile

About Cedergren Jan

Data last updated:

Cedergren Jan has 18 years in corporate governance. Formerly with 1 company, such as India Hiv/Aids Alliance U/S 25. Engaged in General Business. Contributes to corporate operations.

DIN 02662832
Primary Designation Director
First Appointment 24 Apr 2008
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
India Hiv/Aids Alliance U/S 25 U85310DL1999NPL098570
Director24 Apr 20081999Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
India Hiv/Aids Alliance U/S 25
Premium access

Shareholding and investment profile for Cedergren Jan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Cedergren Jan

Cedergren Jan has 18 years in corporate governance. Formerly with 1 company, such as India Hiv/Aids Alliance U/S 25. Engaged in General Business. Contributes to corporate operations.

Cedergren Jan is associated with 0 companies as a director.

Cedergren Jan has expertise in General Business.

Cedergren Jan has 18 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available